Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?

Basit Öğe Kaydı
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridKilickap, Saadettin/0000-0003-1637-7390
dc.authoridEralp, Yesim/0000-0001-9603-4755
dc.authorwosidCoşkun, Hasan Şenol/C-2070-2016
dc.authorwosidŞenler, Filiz Çay/AAI-1824-2019
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidTatlı, Ali Murat/D-9111-2018
dc.authorwosidDemirkazık, Ahmet/AAG-7699-2020
dc.authorwosidKilickap, Saadettin/AAP-3732-2021
dc.authorwosidBasal, Fatma Bugdayci/ABI-4087-2020
dc.contributor.authorKilickap, S.
dc.contributor.authorBasal, F. Bugdayci
dc.contributor.authorDemirkazik, A.
dc.contributor.authorGursoy, P.
dc.contributor.authorDemirci, U.
dc.contributor.authorErman, M.
dc.contributor.authorYumuk, F.
dc.date.accessioned2024-06-12T11:24:07Z
dc.date.available2024-06-12T11:24:07Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description44th Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 27-OCT 01, 2019 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncolen_US
dc.identifier.endpage637en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpage637en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26811
dc.identifier.volume30en_US
dc.identifier.wosWOS:000491295504209en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleIs there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu